cholecystokinin and Hepatitis--Chronic

cholecystokinin has been researched along with Hepatitis--Chronic* in 2 studies

Other Studies

2 other study(ies) available for cholecystokinin and Hepatitis--Chronic

ArticleYear
Effects of homeopathic preparations on the liver in rats with acute and chronic toxic hepatitis.
    Bulletin of experimental biology and medicine, 2003, Volume: 135 Suppl 7

    Ultralow doses of antibodies to phenobarbital and their mixture (1:1) with ultralow doses of antibodies to cholecystokinin reduced the severity of structural and metabolic disturbances in the liver of rats with acute CCl4-induced hepatitis. The mixture of antibodies had no effect on the course of CCl4-induced hepatitis.

    Topics: Animals; Antibodies; Chemical and Drug Induced Liver Injury; Cholecystokinin; Dose-Response Relationship, Drug; Hepatitis, Chronic; Liver; Materia Medica; Phenobarbital; Rats; Rats, Wistar

2003
Hepatoprotective properties of potentiated antibodies to cholecystokinin.
    Bulletin of experimental biology and medicine, 2003, Volume: 135 Suppl 7

    Ultralow doses of antibodies to cholecystokinin prevented hepatocyte death, delayed the formation of the connective tissue, and normalized plasma of liver enzyme in rats with experimental acute and chronic toxic hepatitis.

    Topics: Animals; Antibodies; Chemical and Drug Induced Liver Injury; Cholecystokinin; Hepatitis, Chronic; Liver; Rats; Rats, Wistar

2003